| Product Code: ETC7656966 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurology Clinical Trials Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurology Clinical Trials Market - Industry Life Cycle |
3.4 Israel Neurology Clinical Trials Market - Porter's Five Forces |
3.5 Israel Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Israel Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 Israel Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Israel Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Israel |
4.2.2 Growing investment in healthcare infrastructure and research development |
4.2.3 Rising demand for innovative treatments and therapies in neurology |
4.3 Market Restraints |
4.3.1 Stringent regulations and lengthy approval processes for clinical trials |
4.3.2 Limited availability of skilled neurology clinical trial professionals in Israel |
5 Israel Neurology Clinical Trials Market Trends |
6 Israel Neurology Clinical Trials Market, By Types |
6.1 Israel Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Israel Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 Israel Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 Israel Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 Israel Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Israel Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Israel Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 Israel Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 Israel Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 Israel Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Israel Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 Israel Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 Israel Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 Israel Neurology Clinical Trials Market Export to Major Countries |
7.2 Israel Neurology Clinical Trials Market Imports from Major Countries |
8 Israel Neurology Clinical Trials Market Key Performance Indicators |
8.1 Patient recruitment and retention rates in neurology clinical trials |
8.2 Timeliness and success rate of regulatory approvals for clinical trials in Israel |
8.3 Adoption of novel technologies and methodologies in neurology clinical trials |
9 Israel Neurology Clinical Trials Market - Opportunity Assessment |
9.1 Israel Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Israel Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 Israel Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Israel Neurology Clinical Trials Market - Competitive Landscape |
10.1 Israel Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here